Ref ID: 19603
Author:
T Fontaine1*, L Muszkieta1, A Delangle1, C Simenel2, S Bozza3, S Moretti3, M Delepierre2,
C Elbim4, MS Gresnigt5, FL van de Veerdonk5, L Romani3, JP Latgé1
Author address:
1Unité des Aspergillus, Institut Pasteur, Paris France
2Unité de Résonance Magnétique Nucléaire des Biomolécules, Institut Pasteur, Paris
3Department of experimental medicine and biochemical sciences, University of Perugia, Perugia, Italy
4Univers
Full conference title:
6th Advances Against Aspergillosis 2014
Abstract:
Purpose:
The galactosaminogalactan (GAG) is a new antigenic polysaccharide secreted by the human
opportunistic fungal pathogen Aspergillus fumigatus during infection particularly during invasive
aspergillosis. GAG is also an adhesin involved in the biofilm formation on abiotic support. Structure
and function have been investigated.
Methods:
Immunological studies of GAG were carried on humans cells and murine model. Structural
characterization was performed by carbohydrate analysis using specific chemical degradations,
mass spectrometry and NMR.
Results:
In murine model, GAG promotes fungal development in immunocompetent mice due to its
immunosuppressive activity that is associated to a decrease of neutrophil infiltrates in lung.
Particularly, GAG induced neutrophil apoptosis. Carbohydrate analysis showed that this polysaccharide
is a linear heterogeneous galactosaminogalactan composed of α 1-4 linked galactose and
α 1-4 linked N-acetylgalactosamine residues where both monosacharides are randomly distributed
and with variable percentage of galactose per chain. The apparent Mr was estimated by gel filtration
chromatography, this polysaccharide was eluted as a polydisperse homogenous polymer between 10
and 1000 kDa with an average of 100 kDa. A specific glycosyltransferase has been identified. The
deletion mutant does not produce GAG anymore and its phenotype is currently analysed.
Conclusion:
GAG is the first fungal described immunosuppressive polysaccharide that favours the fungal
infection.
Abstract Number: 128
Conference Year: 2014
Link to conference website: http://www.AAA2014.org
New link: NULL
Conference abstracts, posters & presentations
-
Title
Author
Year
Number
Poster
-
v
Teclegiorgis Gebremariam [MS]1, Yiyou Gu [PhD]1, Sondus Alkhazraji [PhD]1, Jousha Quran1, Laura K. Najvar [BS]2, Nathan P. Wiederhold [PharmD]2, Thomas F. Patterson [MD]2, Scott G. Filler [MD]1,3, David A. Angulo (MD)4, Ashraf S. Ibrahim [PhD]1,3*,
2024
91
n/a
-
v
Ruta Petraitiene (US)
2024
90
n/a
-
v
Fabio Palmieri (CH), Junier Pilar
2024
89
n/a
-
v
Evelyne Côté (CA)
2024
88
n/a
-
v
Eliane Vanhoffelen (BE)
2024
87
n/a
-
v
Teclegiorgis Gebremariam, Yiyou Gu, Eman Youssef, Sondus Alkhazraji, Joshua Quran, Nathan P. Wiederhold, Ashraf S. Ibrahim
2024
86
n/a
-
v
Thomas Orasch (DE)
2024
85
n/a
-
v
Julien Alex, Katherine González, Gauri Gangapurwala, Antje Vollrath, Zoltán Cseresnyés, Christine Weber, Justyna A. Czaplewska, Stephanie Hoeppener, Carl-Magnus Svensson, Thomas Orasch, Thorsten Heinekamp, Carlos Guerrero-Sánchez, Marc Thilo Figge, Ulrich S. Schubert, Axel A. Brakhage
2024
84
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
83
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
82
n/a